Brain serotonin transporter binding in former users of MDMA ('ecstasy').

Selvaraj, Sudhakar; Hoshi, Rosa; Bhagwagar, Zubin; Murthy, Naga Venkatesha; Hinz, Rainer; Cowen, Philip; Curran, H Valerie; Grasby, Paul · Br J Psychiatry · 2009

case_control · Level III

Where this comes from

Abstract

Animal experimental studies have prompted concerns that widespread use of 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') by young people may pose a major public health problem in terms of persistent serotonin neurotoxicity. To determine the status of brain serotonin neurons in a group of abstinent MDMA users. We assessed the integrity of brain serotonin neurons by measuring serotonin transporter (SERT) binding using positron emission tomography (PET) and [(11)C]DASB in 12 former MDMA users, 9 polydrug users who had never taken MDMA and 19 controls who reported no history of illicit drug use. There was no significant difference in the binding potential of [(11)C]DASB between the groups in any of the brain regions examined. To the extent that [(11)C]DASB binding provides an index of the integrity of serotonin neurons, our findings suggest that MDMA use may not result in long-term damage to serotonin neurons when used recreationally in humans.

Medical subject headings